Pregabalin Capsule
Product Images NDC 82619-122

30 FDA label images from Creekwood Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 82619-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Creekwood Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 01)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 01)
A formula calculating creatinine clearance (CLCr) including variables for age in years, weight in kilograms, serum creatinine in mg/dL, and a factor for female patients (0.85). The equation is used for estimating kidney function.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 02)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 02)
Chemical structure of pregabalin, the active ingredient in PREGABALIN capsules by Creekwood Pharmaceuticals LLC, illustrating its molecular configuration including an amino group and carboxyl group attached to a branched carbon chain.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 03)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 03)
A line graph displaying the percent of patients improved versus percent improvement in pain from baseline. The graph compares four groups: Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, Pregabalin 25 mg three times a day, and placebo, showing trends in patient improvement across different pain improvement percentages.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 04)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 04)
A line graph comparing the percent of patients improved versus percent improvement in pain from baseline for Pregabalin 100 mg three times a day and placebo. The graph shows two lines, with Pregabalin demonstrating higher patient improvement at various pain improvement percentages compared to placebo.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 05)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 05)
A line graph showing the percent of patients improved versus percent improvement in pain from baseline for Pregabalin capsules at doses of 75 mg, 150 mg, and 300 mg taken two times a day, compared to placebo. The graph includes multiple curves indicating different dosing groups and placebo response over a range of pain improvement percentages.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 06)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 06)
A line graph depicting the percent of patients improved against percent improvement in pain from baseline. It compares three groups: Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and placebo. The graph shows trends of patient improvement across different pain reduction percentages.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 07)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 07)
A line graph showing the percent of patients improved by different levels of percent improvement in pain from baseline. It compares three groups: Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, and placebo. The y-axis represents the percent of patients improved, and the x-axis shows percent improvement in pain from baseline, with vertical lines at 30% and 50% improvement thresholds.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 08)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 08)
A bar chart comparing responder rates (%) in two clinical studies (E1 and E3) for placebo and pregabalin 600 mg/day by oral dose (divided into BID and TID dosing). The chart shows statistically significant higher response rates for pregabalin compared to placebo in both studies.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 09)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 09)
A line graph illustrating the median percentage reduction in seizure frequency from baseline at various doses (0, 50, 150, 300, 600 mg/day) of pregabalin. Data from four studies (E1 BD, E2 TID, E3 BD, E3 TID) show increased seizure reduction with higher doses, with significant p-values indicated for comparisons to placebo.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 10)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 10)
A bar graph showing the responder rate percentages for three groups: Placebo (22.6%, N=93), 2.5 mg/kg/day Pregabalin (29.1%, N=103), and 10 mg/kg/day Pregabalin (40.6%, N=96). The vertical axis represents responder rate (%) from 0 to 60.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 11)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 11)
A line graph depicting the percentage of patients improved versus percent improvement in pain from baseline. The graph compares Pregabalin at 600 mg, 450 mg, and 300 mg daily doses with placebo, showing trends in patient improvement across different levels of pain reduction.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 12)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 12)
A line graph comparing the estimated percentage of subjects without LTR over time (in days) between Pregabalin and placebo groups. The x-axis represents days from 0 to 180, and the y-axis shows the estimated percentage from 0% to 100%. Two lines show differing trends for Pregabalin and placebo during the study period.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 13)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 13)
A line graph comparing the percent of subjects improved from baseline to Week 12 for Pregabalin versus Placebo. The x-axis shows percent improved, and the y-axis shows percent of subjects improved. Two lines represent Pregabalin (solid) and Placebo (dashed), with Pregabalin consistently showing higher improvement rates over the range.*
FDA Label Image

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 14)

Image (D7bfe644 D306 44a7 8710 4a10af2e0848 14)
A line graph comparing the percent of subjects improved over time from baseline to week 16, measured by BOCF, for Pregabalin versus placebo. The x-axis shows percent improvement from 0 to 100, while the y-axis shows percent of subjects improved from 0 to 100%.*
FDA Label Image

25mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 15)

25mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 15)
Pregabalin Capsules 25 mg oral capsules packaging label showing 90 capsules per container. The label includes storage instructions, manufacturer V-Ensure Pharma Technologies Pvt. Ltd., and distributor Creekwood Pharmaceuticals LLC. It features a barcode, QR code for medication guide, and dosage information.*
FDA Label Image

25mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 16)

25mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 16)
Label for Pregabalin Capsules 25 mg, with NDC 82619-122-02. Contains 500 capsules and is for prescription use only. Manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in India and distributed by Creekwood Pharmaceuticals LLC. Storage instructions specify controlled room temperature. Includes a QR code for package insert and medication guide. Creekwood logo appears at the bottom.*
FDA Label Image

50mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 17)

50mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 17)
Pregabalin 50 mg capsules packaging label from Creekwood Pharmaceuticals LLC, containing 90 capsules. The label shows the product name, strength, and dosage form along with storage instructions, manufacturing and distribution information. It includes a barcode and QR code for package insert and medication guide access, and indicates the product is prescription only.*
FDA Label Image

50mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 18)

50mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 18)
Pregabalin Capsules 50 mg oral capsules, NDC 82619-123-02, labeled for prescription use and distributed by Creekwood Pharmaceuticals LLC. The package contains 500 capsules. Manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in India. The label includes storage instructions and a QR code linking to the medication guide and package insert.*
FDA Label Image

75mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 19)

75mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 19)
Pregabalin Capsules 75 mg packaging label, NDC 82619-124-01, containing 90 capsules. The label shows the proprietary name Pregabalin, strength 75 mg, dosage form capsule, and is for prescription use only. Manufactured by V-Ensure Pharma Technologies Pvt. Ltd., India, and distributed by Creekwood Pharmaceuticals LLC, Parsippany, NJ. Includes a QR code for package insert and medication guide.*
FDA Label Image

75mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 20)

75mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 20)
Pregabalin Capsules 75 mg oral capsules packaging label. The label indicates a count of 500 capsules and is for prescription use only. It is manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in India and distributed by Creekwood Pharmaceuticals LLC. The label includes storage instructions and a QR code linking to the package insert and medication guide.*
FDA Label Image

100mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 21)

100mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 21)
Pregabalin Capsules 100 mg label showing packaging for 90 capsules. The label includes the NDC 82619-125-01 and indicates the product is for prescription use only. Manufactured by V-Ensure Pharma Technologies Pvt. Ltd. and distributed by Creekwood Pharmaceuticals LLC. The label also features storage instructions, a barcode, and a QR code linking to the package insert and medication guide.*
FDA Label Image

100mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 22)

100mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 22)
Label for Pregabalin Capsules 100 mg manufactured by V-Ensure Pharma Technologies Pvt. Ltd. and distributed by Creekwood Pharmaceuticals LLC. The label indicates a package of 500 capsules for oral use, with storage instructions and a QR code linking to the package insert and medication guide. The label features the Creekwood logo and states Rx Only.*
FDA Label Image

150mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 23)

150mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 23)
Pregabalin Capsules 150 mg label showing a 90-capsule bottle distributed by Creekwood Pharmaceuticals LLC and manufactured by V-Ensure Pharma Technologies Pvt. Ltd. The label includes storage instructions, a QR code for medication guide, and states the capsules contain 150 mg pregabalin each. It also notes the product is prescription only and includes the NDC 82619-126-01.*
FDA Label Image

150mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 24)

150mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 24)
Label for Pregabalin Capsules 150 mg, oral capsules manufactured by V-Ensure Pharma Technologies Pvt. Ltd. and distributed by Creekwood Pharmaceuticals LLC. The label shows a package size of 500 capsules with storage instructions and a QR code for the package insert and medication guide. The label includes the NDC code 82619-126-02 and a medication guide warning to always dispense with the medication guide.*
FDA Label Image

200mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 25)

200mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 25)
Label for Pregabalin Capsules 200 mg by Creekwood Pharmaceuticals LLC. The label indicates 90 capsules per package and states the product is prescription only (Rx Only). Manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in India, with storage instructions at 20° to 25°C. Includes reminders to dispense with a medication guide and storage and packaging details.*
FDA Label Image

200mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 26)

200mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 26)
Label for Pregabalin Capsules 200 mg by Creekwood Pharmaceuticals LLC. The label indicates a packaging size of 500 capsules, Rx only. It includes storage instructions and states the capsules contain Pregabalin USP 200 mg. Manufactured by V-Ensure Pharma Technologies Pvt. Ltd., India, and distributed by Creekwood Pharmaceuticals in Parsippany, NJ. A barcode and QR code for package insert and medication guide are also present.*
FDA Label Image

225mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 27)

225mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 27)
Pregabalin Capsules 225 mg label showing a prescription drug package containing 90 capsules. The label identifies Pregabalin as the active ingredient with the dosage strength of 225 mg per capsule. It is distributed by Creekwood Pharmaceuticals LLC and manufactured by V-Ensure Pharma Technologies Pvt. Ltd. The label includes storage instructions, a QR code for the medication guide, and a barcode.*
FDA Label Image

225mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 28)

225mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 28)
Label for Pregabalin Capsules 225 mg, distributed by Creekwood Pharmaceuticals LLC. The label indicates 500 capsules in the package with Rx only status. Manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in India. Storage instructions specify controlled room temperature with allowable excursions. The label includes a barcode, a QR code for the package insert and medication guide, and a note to dispense with the medication guide.*
FDA Label Image

300mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 29)

300mg-90s (D7bfe644 D306 44a7 8710 4a10af2e0848 29)
Label for Pregabalin Capsules 300 mg, oral capsules supplied in a count of 90. The label includes storage instructions, usual dosage directions, and manufacturer information (V-Ensure Pharma Technologies Pvt. Ltd., India) with distribution by Creekwood Pharmaceuticals LLC, Parsippany, NJ. The label features prescription-only status and a barcode.*
FDA Label Image

300mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 30)

300mg-500s (D7bfe644 D306 44a7 8710 4a10af2e0848 30)
Label for Pregabalin capsules 300 mg, containing 500 capsules. The label includes storage instructions for controlled room temperature and indicates the product is Rx only. Manufactured by V-Ensure Pharma Technologies Pvt. Ltd., India, and distributed by Creekwood Pharmaceuticals LLC. The label features the NDC 82619-129-02 and a QR code linking to the package insert and medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.